All News

Candice Sherman, CEO of the Northeast Business Group on Health.

Ensuring that employees have the assistance and tools necessary to meet telehealth and behavioral health demands is vital to promote safety and health amid the pandemic, along with lowering or eliminating out-of-pocket costs that can steer people away from cancer screenings, therapies, or aspects of high-value care.

Last year, a data monitoring committee halted the DAPA-CKD trial when it found the evidence of efficacy was overwhelming, after it was shown the trial met all its primary and secondary end points for patients with chronic kidney disease, with and without type 2 diabetes.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo